Entry - #609311 - CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4H; CMT4H - OMIM
# 609311

CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4H; CMT4H


Alternative titles; symbols

CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL RECESSIVE, TYPE 4H
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4H
CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4H


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
12p11.21 Charcot-Marie-Tooth disease, type 4H 609311 AR 3 FGD4 611104
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
SKELETAL
Spine
- Scoliosis
Feet
- Pes cavus
- Pes equinus
NEUROLOGIC
Peripheral Nervous System
- Delayed motor development
- Distal lower limb muscle weakness due to peripheral neuropathy
- Distal lower limb muscle atrophy due to peripheral neuropathy
- Upper limb involvement may occur later
- 'Waddling' gait
- Distal sensory impairment
- Hyporeflexia
- Areflexia
- Decreased motor nerve conduction velocity (NCV) (less than 38 m/s)
- Nerve biopsy shows demyelination/remyelination
- Nerve biopsy shows 'onion bulb' formations
- Nerve biopsy shows decreased number of myelinated fibers
MISCELLANEOUS
- Onset before age 2 years
- Usually begins in feet and legs (peroneal distribution)
- Severe disorder
- Genetic heterogeneity (see CMT4A 214400)
MOLECULAR BASIS
- Caused by mutation in the FYVE, RhoGEF, and PH domain-containing protein-4 gene (FGD4, 611104.0001)
Charcot-Marie-Tooth disease - PS118220 - 82 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.31 Charcot-Marie-Tooth disease, recessive intermediate C AR 3 615376 PLEKHG5 611101
1p36.22 Charcot-Marie-Tooth disease, type 2A1 AD 3 118210 KIF1B 605995
1p36.22 Hereditary motor and sensory neuropathy VIA AD 3 601152 MFN2 608507
1p36.22 Charcot-Marie-Tooth disease, axonal, type 2A2B AR 3 617087 MFN2 608507
1p36.22 Charcot-Marie-Tooth disease, axonal, type 2A2A AD 3 609260 MFN2 608507
1p35.1 Charcot-Marie-Tooth disease, dominant intermediate C AD 3 608323 YARS1 603623
1p13.1 Charcot-Marie-Tooth disease, axonal, type 2DD AD 3 618036 ATP1A1 182310
1q22 Charcot-Marie-Tooth disease, type 2B1 AR 3 605588 LMNA 150330
1q23.2 Charcot-Marie-Tooth disease, axonal, type 2FF AD 3 619519 CADM3 609743
1q23.3 Charcot-Marie-Tooth disease, type 1B AD 3 118200 MPZ 159440
1q23.3 Charcot-Marie-Tooth disease, type 2I AD 3 607677 MPZ 159440
1q23.3 Charcot-Marie-Tooth disease, dominant intermediate D AD 3 607791 MPZ 159440
1q23.3 Charcot-Marie-Tooth disease, type 2J AD 3 607736 MPZ 159440
1q23.3 Dejerine-Sottas disease AD, AR 3 145900 MPZ 159440
2p23.3 Charcot-Marie-Tooth disease, axonal, type 2EE AR 3 618400 MPV17 137960
3q21.3 Charcot-Marie-Tooth disease, type 2B AD 3 600882 RAB7 602298
3q25.2 Charcot-Marie-Tooth disease, axonal, type 2T AD, AR 3 617017 MME 120520
3q26.33 Charcot-Marie-Tooth disease, dominant intermediate F AD 3 615185 GNB4 610863
4q31.3 Charcot-Marie-Tooth disease, type 2R AR 3 615490 TRIM2 614141
5q31.3 Charcot-Marie-Tooth disease, axonal, type 2W AD 3 616625 HARS1 142810
5q32 Charcot-Marie-Tooth disease, type 4C AR 3 601596 SH3TC2 608206
6p21.31 Charcot-Marie-Tooth disease, demyelinating, type 1J AD 3 620111 ITPR3 147267
6q21 Charcot-Marie-Tooth disease, type 4J AR 3 611228 FIG4 609390
7p14.3 Charcot-Marie-Tooth disease, type 2D AD 3 601472 GARS1 600287
7q11.23 Charcot-Marie-Tooth disease, axonal, type 2F AD 3 606595 HSPB1 602195
8p21.2 Charcot-Marie-Tooth disease, dominant intermediate G AD 3 617882 NEFL 162280
8p21.2 Charcot-Marie-Tooth disease, type 2E AD 3 607684 NEFL 162280
8p21.2 Charcot-Marie-Tooth disease, type 1F AD, AR 3 607734 NEFL 162280
8q13-q23 Charcot-Marie-Tooth disease, axonal, type 2H AR 2 607731 CMT2H 607731
8q21.11 {?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, modifier of} AD, AR 3 607831 JPH1 605266
8q21.11 Charcot-Marie-Tooth disease, type 4A AR 3 214400 GDAP1 606598
8q21.11 Charcot-Marie-Tooth disease, axonal, type 2K AD, AR 3 607831 GDAP1 606598
8q21.11 Charcot-Marie-Tooth disease, recessive intermediate, A AR 3 608340 GDAP1 606598
8q21.11 Charcot-Marie-Tooth disease, axonal, with vocal cord paresis AR 3 607706 GDAP1 606598
8q21.13 Charcot-Marie-Tooth disease, demyelinating, type 1G AD 3 618279 PMP2 170715
8q24.22 Charcot-Marie-Tooth disease, type 4D AR 3 601455 NDRG1 605262
9p13.3 Charcot-Marie-Tooth disease, type 2Y AD 3 616687 VCP 601023
9q33.3-q34.11 Charcot-Marie-Tooth disease, axonal, type 2P AD, AR 3 614436 LRSAM1 610933
9q34.2 Charcot-Marie-Tooth disease, type 4K AR 3 616684 SURF1 185620
10p14 ?Charcot-Marie-Tooth disease, axonal, type 2Q AD 3 615025 DHTKD1 614984
10q21.3 Charcot-Marie-Tooth disease, type 1D AD 3 607678 EGR2 129010
10q21.3 Dejerine-Sottas disease AD, AR 3 145900 EGR2 129010
10q21.3 Hypomyelinating neuropathy, congenital, 1 AD, AR 3 605253 EGR2 129010
10q22.1 Neuropathy, hereditary motor and sensory, Russe type AR 3 605285 HK1 142600
10q24.32 Charcot-Marie-Tooth disease, axonal, type 2GG AD 3 606483 GBF1 603698
10q26.11 Charcot-Marie-Tooth disease, axonal, type 2JJ AD 3 621095 BAG3 603883
11p15.4 Charcot-Marie-Tooth disease, type 4B2 AR 3 604563 SBF2 607697
11q13.3 Charcot-Marie-Tooth disease, axonal, type 2S AR 3 616155 IGHMBP2 600502
11q21 Charcot-Marie-Tooth disease, type 4B1 AR 3 601382 MTMR2 603557
12p11.21 Charcot-Marie-Tooth disease, type 4H AR 3 609311 FGD4 611104
12q13.3 Charcot-Marie-Tooth disease, axonal, type 2U AD 3 616280 MARS1 156560
12q23.3 Charcot-Marie-Tooth disease, demyelinating, type 1I AD 3 619742 POLR3B 614366
12q24.11 Hereditary motor and sensory neuropathy, type IIc AD 3 606071 TRPV4 605427
12q24.23 Charcot-Marie-Tooth disease, axonal, type 2L AD 3 608673 HSPB8 608014
12q24.31 Charcot-Marie-Tooth disease, recessive intermediate D AR 3 616039 COX6A1 602072
14q32.12 Charcot-Marie-Tooth disease, demyelinating, type 1H AD 3 619764 FBLN5 604580
14q32.31 Charcot-Marie-Tooth disease, axonal, type 2O AD 3 614228 DYNC1H1 600112
14q32.33 Charcot-Marie-Tooth disease, dominant intermediate E AD 3 614455 INF2 610982
15q14 Charcot-Marie-Tooth disease, axonal, type 2II AD 3 620068 SLC12A6 604878
15q21.1 Charcot-Marie-Tooth disease, axonal, type 2X AR 3 616668 SPG11 610844
16p13.13 Charcot-Marie-Tooth disease, type 1C AD 3 601098 LITAF 603795
16q22.1 Charcot-Marie-Tooth disease, axonal, type 2N AD 3 613287 AARS1 601065
16q23.1 ?Charcot-Marie-Tooth disease, recessive intermediate, B AR 3 613641 KARS1 601421
17p12 Dejerine-Sottas disease AD, AR 3 145900 PMP22 601097
17p12 Charcot-Marie-Tooth disease, type 1E AD 3 118300 PMP22 601097
17p12 Charcot-Marie-Tooth disease, type 1A AD 3 118220 PMP22 601097
17q21.2 ?Charcot-Marie-Tooth disease, axonal, type 2V AD 3 616491 NAGLU 609701
19p13.2 Charcot-Marie-Tooth disease, dominant intermediate B AD 3 606482 DNM2 602378
19p13.2 Charcot-Marie-Tooth disease, axonal type 2M AD 3 606482 DNM2 602378
19q13.2 Charcot-Marie-Tooth disease, type 4F AR 3 614895 PRX 605725
19q13.2 Dejerine-Sottas disease AD, AR 3 145900 PRX 605725
19q13.33 ?Charcot-Marie-Tooth disease, type 2B2 AR 3 605589 PNKP 605610
20p12.2 Charcot-Marie-Tooth disease, axonal, type 2HH AD 3 619574 JAG1 601920
22q12.2 Charcot-Marie-Tooth disease, axonal, type 2CC AD 3 616924 NEFH 162230
22q12.2 Charcot-Marie-Tooth disease, axonal, type 2Z AD 3 616688 MORC2 616661
22q13.33 Charcot-Marie-Tooth disease, type 4B3 AR 3 615284 SBF1 603560
Xp22.2 Charcot-Marie-Tooth neuropathy, X-linked recessive, 2 XLR 2 302801 CMTX2 302801
Xp22.11 ?Charcot-Marie-Tooth disease, X-linked dominant, 6 XLD 3 300905 PDK3 300906
Xq13.1 Charcot-Marie-Tooth neuropathy, X-linked dominant, 1 XLD 3 302800 GJB1 304040
Xq22.3 Charcot-Marie-Tooth disease, X-linked recessive, 5 XLR 3 311070 PRPS1 311850
Xq26 Charcot-Marie-Tooth neuropathy, X-linked recessive, 3 XLR 4 302802 CMTX3 302802
Xq26.1 Cowchock syndrome XLR 3 310490 AIFM1 300169

TEXT

A number sign (#) is used with this entry because of evidence that Charcot-Marie-Tooth disease type 4H (CMT4H) is caused by homozygous mutation in the gene encoding frabin (FGD4; 611104) on chromosome 12p11.

For a discussion of genetic heterogeneity of autosomal recessive Charcot-Marie-Tooth disease, see CMT4A (214400).


Clinical Features

De Sandre-Giovannoli et al. (2005) reported a total of 10 individuals from 2 families, 1 Lebanese and 1 Algerian, with a severe form of CMT. Onset occurred within the first 2 years of life and was manifested by delayed walking, unsteady gait, areflexia, scoliosis, and foot abnormalities, including pes cavus and pes equinus. Two members of the Lebanese family had upper limb involvement with thenar and hypothenar hypoplasia. Electrophysiologic studies showed severely reduced motor and sensory nerve conduction velocities, consistent with a demyelinating process. Sural nerve biopsy of 1 member of the Lebanese family showed severe loss of myelinated fibers, as well as some features of congenital hypomyelination and occasional onion bulb formations. The Algerian family was consanguineous, suggesting autosomal recessive inheritance.

Houlden et al. (2009) reported 2 sibs with CMT4H confirmed by genetic analysis (R275X; 611104.0006). Although both patients had onset of walking difficulties in childhood, there was slow progression of the disorder, and both remained ambulatory into middle age. At age 58, the proband had pes cavus, distal muscle weakness and atrophy, areflexia, stocking and glove sensory loss, and pupil size asymmetry. Her brother had a similar phenotype. Nerve conduction velocities were significantly decreased. Houlden et al. (2009) noted that the phenotype was relatively mild compared to patients with other FGD4 mutations.

Fabrizi et al. (2009) reported a 20-year-old woman, born of consanguineous Italian parents, with CMT4H confirmed by genetic analysis (611104.0007). The patient was from a small mountain village in northeast Italy. She had a clumsy gait since childhood, steppage gait, pes equinovarus, lower limb areflexia, and mild distal sensory loss. She also had scoliosis and hypotrophy of thenar and hypothenar muscles. Pathologic and electrophysiologic studies showed a demyelinating neuropathy. There was slow disease progression.


Inheritance

The transmission pattern of CMT4H in the Algerian family reported by De Sandre-Giovannoli et al. (2005) was consistent with autosomal recessive inheritance.


Mapping

In 2 unrelated families with severe early-onset demyelinating CMT, De Sandre-Giovannoli et al. (2005) found linkage of the disorder, designated CMT4H, to an 11.5-cM region on chromosome 12p11.21-q13.11 between markers D12S1648 and D12S1661 (maximum pairwise lod score of 6.97 at D12S345). Mutation analysis excluded peripherin (PRPH; 170710) and contactin-1 (CNTN1; 600016) as candidate genes.


Molecular Genetics

In affected members of the Lebanese and Algerian families with CMT4H reported by De Sandre-Giovannoli et al. (2005), Delague et al. (2007) identified 2 different homozygous mutations in the FGD4 gene (611104.0002 and 611104.0005, respectively). Stendel et al. (2007) also identified homozygous mutations in the FGD4 gene in patients with CMT4H (611104.0001-611104.0005).


REFERENCES

  1. De Sandre-Giovannoli, A., Delague, V., Hamadouche, T., Chaouch, M., Krahn, M., Boccaccio, I., Maisonobe, T., Chouery, E., Jabbour, R., Atweh, S., Grid, D., Megarbane, A., Levy, N. Homozygosity mapping of autosomal recessive demyelinating Charcot-Marie-Tooth neuropathy (CMT4H) to a novel locus on chromosome 12p11.21-q13.11. (Letter) J. Med. Genet. 42: 260-265, 2005. [PubMed: 15744041, related citations] [Full Text]

  2. Delague, V., Jacquier, A., Hamadouche, T., Poitelon, Y., Baudot, C., Boccaccio, I., Chouery, E., Chaouch, M., Kassouri, N., Jabbour, R., Grid, D., Megarbane, A., Haase, G., Levy, N. Mutations in FGD4 encoding the Rho GDP/GTP exchange factor frabin cause autosomal recessive Charcot-Marie-Tooth type 4H. Am. J. Hum. Genet. 81: 1-16, 2007. [PubMed: 17564959, images, related citations] [Full Text]

  3. Fabrizi, G. M., Taioli, F., Cavallaro, T., Ferrari, S., Bertolasi, L., Casarotto, M., Rizzuto, N., Deconinck, T., Timmerman, V., De Jonghe, P. Further evidence that mutations in FGD4/frabin cause Charcot-Marie-Tooth disease type 4H. Neurology 72: 1160-1164, 2009. [PubMed: 19332693, related citations] [Full Text]

  4. Houlden, H., Hammans, S., Katifi, H., Reilly, M. M. A novel frabin (FGD4) nonsense mutation p.R275X associated with phenotypic variability in CMT4H. Neurology 72: 617-620, 2009. [PubMed: 19221294, images, related citations] [Full Text]

  5. Stendel, C., Roos, A., Deconinck, T., Pereira, J., Castagner, F., Niemann, A., Kirschner, J., Korinthenberg, R., Ketelsen, U.-P., Battaloglu, E., Parman, Y., Nicholson, G., and 12 others. Peripheral nerve demyelination caused by a mutant Rho GTPase guanine nucleotide exchange factor, Frabin/FGD4. Am. J. Hum. Genet. 81: 158-164, 2007. [PubMed: 17564972, images, related citations] [Full Text]


Cassandra L. Kniffin - updated : 6/29/2009
Cassandra L. Kniffin - updated : 3/16/2009
Cassandra L. Kniffin - updated : 8/22/2007
Victor A. McKusick - updated : 6/19/2007
Creation Date:
Cassandra L. Kniffin : 4/15/2005
carol : 09/09/2024
carol : 03/03/2021
carol : 11/07/2016
wwang : 07/28/2009
ckniffin : 6/29/2009
wwang : 3/26/2009
ckniffin : 3/16/2009
alopez : 8/24/2007
ckniffin : 8/22/2007
alopez : 6/20/2007
terry : 6/19/2007
carol : 4/19/2005
wwang : 4/18/2005
ckniffin : 4/15/2005

# 609311

CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4H; CMT4H


Alternative titles; symbols

CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL RECESSIVE, TYPE 4H
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4H
CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4H


SNOMEDCT: 715802008;   ORPHA: 99954;   DO: 0110192;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
12p11.21 Charcot-Marie-Tooth disease, type 4H 609311 Autosomal recessive 3 FGD4 611104

TEXT

A number sign (#) is used with this entry because of evidence that Charcot-Marie-Tooth disease type 4H (CMT4H) is caused by homozygous mutation in the gene encoding frabin (FGD4; 611104) on chromosome 12p11.

For a discussion of genetic heterogeneity of autosomal recessive Charcot-Marie-Tooth disease, see CMT4A (214400).


Clinical Features

De Sandre-Giovannoli et al. (2005) reported a total of 10 individuals from 2 families, 1 Lebanese and 1 Algerian, with a severe form of CMT. Onset occurred within the first 2 years of life and was manifested by delayed walking, unsteady gait, areflexia, scoliosis, and foot abnormalities, including pes cavus and pes equinus. Two members of the Lebanese family had upper limb involvement with thenar and hypothenar hypoplasia. Electrophysiologic studies showed severely reduced motor and sensory nerve conduction velocities, consistent with a demyelinating process. Sural nerve biopsy of 1 member of the Lebanese family showed severe loss of myelinated fibers, as well as some features of congenital hypomyelination and occasional onion bulb formations. The Algerian family was consanguineous, suggesting autosomal recessive inheritance.

Houlden et al. (2009) reported 2 sibs with CMT4H confirmed by genetic analysis (R275X; 611104.0006). Although both patients had onset of walking difficulties in childhood, there was slow progression of the disorder, and both remained ambulatory into middle age. At age 58, the proband had pes cavus, distal muscle weakness and atrophy, areflexia, stocking and glove sensory loss, and pupil size asymmetry. Her brother had a similar phenotype. Nerve conduction velocities were significantly decreased. Houlden et al. (2009) noted that the phenotype was relatively mild compared to patients with other FGD4 mutations.

Fabrizi et al. (2009) reported a 20-year-old woman, born of consanguineous Italian parents, with CMT4H confirmed by genetic analysis (611104.0007). The patient was from a small mountain village in northeast Italy. She had a clumsy gait since childhood, steppage gait, pes equinovarus, lower limb areflexia, and mild distal sensory loss. She also had scoliosis and hypotrophy of thenar and hypothenar muscles. Pathologic and electrophysiologic studies showed a demyelinating neuropathy. There was slow disease progression.


Inheritance

The transmission pattern of CMT4H in the Algerian family reported by De Sandre-Giovannoli et al. (2005) was consistent with autosomal recessive inheritance.


Mapping

In 2 unrelated families with severe early-onset demyelinating CMT, De Sandre-Giovannoli et al. (2005) found linkage of the disorder, designated CMT4H, to an 11.5-cM region on chromosome 12p11.21-q13.11 between markers D12S1648 and D12S1661 (maximum pairwise lod score of 6.97 at D12S345). Mutation analysis excluded peripherin (PRPH; 170710) and contactin-1 (CNTN1; 600016) as candidate genes.


Molecular Genetics

In affected members of the Lebanese and Algerian families with CMT4H reported by De Sandre-Giovannoli et al. (2005), Delague et al. (2007) identified 2 different homozygous mutations in the FGD4 gene (611104.0002 and 611104.0005, respectively). Stendel et al. (2007) also identified homozygous mutations in the FGD4 gene in patients with CMT4H (611104.0001-611104.0005).


REFERENCES

  1. De Sandre-Giovannoli, A., Delague, V., Hamadouche, T., Chaouch, M., Krahn, M., Boccaccio, I., Maisonobe, T., Chouery, E., Jabbour, R., Atweh, S., Grid, D., Megarbane, A., Levy, N. Homozygosity mapping of autosomal recessive demyelinating Charcot-Marie-Tooth neuropathy (CMT4H) to a novel locus on chromosome 12p11.21-q13.11. (Letter) J. Med. Genet. 42: 260-265, 2005. [PubMed: 15744041] [Full Text: https://doi.org/10.1136/jmg.2004.024364]

  2. Delague, V., Jacquier, A., Hamadouche, T., Poitelon, Y., Baudot, C., Boccaccio, I., Chouery, E., Chaouch, M., Kassouri, N., Jabbour, R., Grid, D., Megarbane, A., Haase, G., Levy, N. Mutations in FGD4 encoding the Rho GDP/GTP exchange factor frabin cause autosomal recessive Charcot-Marie-Tooth type 4H. Am. J. Hum. Genet. 81: 1-16, 2007. [PubMed: 17564959] [Full Text: https://doi.org/10.1086/518428]

  3. Fabrizi, G. M., Taioli, F., Cavallaro, T., Ferrari, S., Bertolasi, L., Casarotto, M., Rizzuto, N., Deconinck, T., Timmerman, V., De Jonghe, P. Further evidence that mutations in FGD4/frabin cause Charcot-Marie-Tooth disease type 4H. Neurology 72: 1160-1164, 2009. [PubMed: 19332693] [Full Text: https://doi.org/10.1212/01.wnl.0000345373.58618.b6]

  4. Houlden, H., Hammans, S., Katifi, H., Reilly, M. M. A novel frabin (FGD4) nonsense mutation p.R275X associated with phenotypic variability in CMT4H. Neurology 72: 617-620, 2009. [PubMed: 19221294] [Full Text: https://doi.org/10.1212/01.wnl.0000342463.35089.cc]

  5. Stendel, C., Roos, A., Deconinck, T., Pereira, J., Castagner, F., Niemann, A., Kirschner, J., Korinthenberg, R., Ketelsen, U.-P., Battaloglu, E., Parman, Y., Nicholson, G., and 12 others. Peripheral nerve demyelination caused by a mutant Rho GTPase guanine nucleotide exchange factor, Frabin/FGD4. Am. J. Hum. Genet. 81: 158-164, 2007. [PubMed: 17564972] [Full Text: https://doi.org/10.1086/518770]


Contributors:
Cassandra L. Kniffin - updated : 6/29/2009
Cassandra L. Kniffin - updated : 3/16/2009
Cassandra L. Kniffin - updated : 8/22/2007
Victor A. McKusick - updated : 6/19/2007

Creation Date:
Cassandra L. Kniffin : 4/15/2005

Edit History:
carol : 09/09/2024
carol : 03/03/2021
carol : 11/07/2016
wwang : 07/28/2009
ckniffin : 6/29/2009
wwang : 3/26/2009
ckniffin : 3/16/2009
alopez : 8/24/2007
ckniffin : 8/22/2007
alopez : 6/20/2007
terry : 6/19/2007
carol : 4/19/2005
wwang : 4/18/2005
ckniffin : 4/15/2005